Skip to Content

WPI 3154 (Modafinil 100 mg)

Pill with imprint WPI 3154 is White, Capsule-shape and has been identified as Modafinil 100 mg. It is supplied by Watson Laboratories, Inc..

Modafinil is used in the treatment of narcolepsy; shift work sleep disorder; chronic fatigue syndrome; obstructive sleep apnea/hypopnea syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3154

Modafinil

Imprint:
WPI 3154
Strength:
100 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3499

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide